Category: Wall Street Beat
Hologic puts black ink back in its fiscal Q1 ledger, meeting The Street with its fiscal 1st-quarter earnings and boosting its sales outlook for the rest of the year.
Hologic (NSDQ:HOLX) raised its sales guidance for fiscal 2015 after reporting robust fiscal 1st-quarter results.
A trio of medical device companies priced their IPOs yesterday, with Avinger and Entellus upsizing their offerings and Presbia pricing under range.
It was medtech IPO day on Wall Street yesterday as a trio of medical device companies priced their initial public offerings.
Here's a look at some of the top Wall Street stories for medical device companies this week: Asante Solutions sets IPO terms; Stryker CEO Lobo: M&A is our top priority for cash; Abiomed surges on Q3 numbers, FDA nod; Credit agencies lower Medtronic's rating post-Covidien merger
Credit agencies Standard & Poor's and Moody's lowered their ratings as promised on Medtronic after it took out a massive debt package to finance its $50 billion acquisition of Covidien.
Abiomed shares surge to an all-time high after the heart pump maker crushes expectations with its fiscal 3rd-quarter results and raises its outlook for the rest of fiscal 2015.
Abiomed (NSDQ:ABMD) shares surged to an all-time high today after the heart pump maker crushed expectations for its fiscal 3rd quarter and raised its outlook on the rest of the year.
Stryker CEO Kevin Lobo says acquisitions are the top priority for the $1.8 billion in ready cash the orthopedics giant is carrying on its balance sheet.